Diseases, Conditions, Syndromes

Can we withdraw treatment in post-menopausal osteoporosis?

Bisphosphonates are the recommended first-line treatment in post-menopausal osteoporosis, with denosumab recommended second-line. Based on the length of clinical trials for bisphosphonates, these drugs are usually prescribed ...


France records growing number of supercentenarians

The number of people in France living beyond 110 years is growing fast, the national demographic studies institute said Wednesday, with women dominating the supercentenarian contest.


Pharmacy researchers examine trends in rising cost of medicine

Newly published research from the University of Houston College of Pharmacy reveals an alarming trend in diabetic medication expenditures. While pharmaceutical spending in the U.S. has long been recognized as higher than ...

page 1 from 34